Policy & Regulation

The outlook for new clinical trials legislation in Europe

Read more

UK Biotech needs a subtle culture shift

Read more

FDA lays out regulatory science strategy

Read more

Denmark has introduced new procedures for ADRs

Read more

Developing biosimilar monoclonal antibodies will not be easy

Read more

Securing Europe's lead in vaccine research

Read more

Proposed UK 'patent box' unveiled

Read more

EMA guidance on biosimilar monoclonal antibodies

Read more

An interview with Thomas Lönngren -- Managing change at the EMA

Read more

European Commission lifts funding for innovation

Read more